Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1526013

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1526013

Drug Delivery Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

PUBLISHED:
PAGES: 140 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4900
PDF & Excel (Multi User License)
USD 6400
PDF & Excel (Corporate User License)
USD 7400

Add to Cart

Description

Table of Contents

Persistence Market Research has recently released a comprehensive report on the global market for drug delivery devices. This report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Drug Delivery Devices Market Size (2024E): USD 44.2 Bn
  • Projected Market Value (2033F): USD 90.2 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 8.2%

Drug Delivery Devices Market - Report Scope:

Drug delivery devices are essential for the efficient and controlled administration of medications to patients. These devices include insulin pens, inhalers, transdermal patches, and implantable drug delivery systems, each designed to enhance therapeutic outcomes and improve patient compliance. The drug delivery devices market caters to a variety of therapeutic areas, including diabetes management, respiratory diseases, and cancer treatment. The market's growth is driven by increasing prevalence of chronic diseases, advancements in drug delivery technologies, and rising demand for self-administered drug delivery solutions.

Market Growth Drivers:

The global drug delivery devices market is propelled by several key factors, including the growing prevalence of chronic diseases such as diabetes and asthma, which necessitate continuous and efficient drug delivery solutions. The rise in geriatric populations and the corresponding increase in age-related health conditions further drive demand for advanced drug delivery systems. Technological advancements, such as the development of smart drug delivery devices and innovations in micro-needle technologies, offer improved patient adherence and precise drug dosing. Additionally, the growing emphasis on personalized medicine and home-based care solutions fuels market growth by expanding the application of drug delivery devices in various healthcare settings.

Market Restraints:

Despite promising growth prospects, the drug delivery devices market faces challenges related to high costs, regulatory hurdles, and complex manufacturing processes. The development and production of advanced drug delivery systems involve significant investment in R&D and compliance with stringent regulatory standards, which can impede market entry for smaller players. Furthermore, the high cost of sophisticated drug delivery devices may limit their accessibility, particularly in emerging economies with constrained healthcare budgets. Addressing these economic and regulatory barriers requires concerted efforts from industry stakeholders and policymakers to enhance market accessibility and affordability.

Market Opportunities:

The drug delivery devices market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital technologies, such as connected inhalers and smart insulin pens, enhances patient engagement and treatment outcomes. The expansion of telehealth services and the growing trend of home-based healthcare create new avenues for the deployment of drug delivery devices. Additionally, the development of novel drug delivery systems, such as biodegradable implants and sustained-release formulations, offers promising prospects for addressing unmet medical needs and driving market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the drug delivery devices market globally?
  • Which types of drug delivery devices are seeing the highest adoption across different therapeutic areas?
  • How are technological advancements reshaping the competitive landscape of the drug delivery devices market?
  • Who are the key players contributing to the drug delivery devices market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global drug delivery devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global drug delivery devices market, including Medtronic plc, Johnson & Johnson, and Abbott Laboratories, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced drug delivery solutions, including smart devices, wearable technologies, and implantable systems, catering to diverse therapeutic needs. Collaborations with healthcare providers, pharmaceutical companies, and regulatory bodies facilitate market access and promote technology adoption. Emphasis on clinical research, user experience, and patient-centered design fosters market growth and enhances treatment outcomes in the evolving drug delivery devices landscape.

Key Companies Profiled:

  • Eli Lilly and Company
  • Becton Dickinson & Co.
  • Novo Nordisk
  • Sanofi
  • Johnson & Johnson
  • Roche
  • Pfizer
  • AbbVie
  • Mylan N.V. (Viatris)
  • Insulet corporation
  • Medtronic Plc

Drug Delivery Devices Market Segmentation

By Product

  • Self-Injectors
  • Auto Injectors
  • Wearable Injectors

By Usage

  • Reusable Devices
  • Disposable Devices

By Route of Administration

  • Transdermal
  • Subcutaneous
  • Intramuscular

By Sales Channel:

  • Hospitals
  • Specialty Clinics
  • Retail Pharmacy Chains

By Applications

  • Diabetes
  • Cancer
  • Hormonal Therapy

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa
Show more
Product Code: PMRREP4091

Table of Contents

1. Executive Summary

  • 1.1. Global Drug Delivery System Market Snapshot, 2024-2033
  • 1.2. Market Opportunity Assessment, 2024-2033 , US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Adoption / Usage Analysis, By Region
  • 2.4. PESTLE Analysis
  • 2.5. Drug Delivery System Market: Value Chain Analysis
  • 2.6. Porter Five Force's Analysis
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Healthcare Outlook
    • 2.7.2. Global Medical Devices Industry Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory Scenario, by Country
    • 2.9.1. Regulatory Frameworks in U.S.
    • 2.9.2. Regulatory Frameworks in Canada
    • 2.9.3. Regulatory Frameworks in Europe
    • 2.9.4. Regulatory Frameworks in Brazil
    • 2.9.5. Regulatory Frameworks in China
    • 2.9.6. Regulatory Frameworks in Japan
    • 2.9.7. Regulatory Frameworks in India
    • 2.9.8. Regulatory Frameworks in Australia

3. Global Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )

  • 3.1. Key Highlights
    • 3.1.1. Market Value (US$ in Bn ) and Volume (in Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Bn ) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019-2023
    • 3.2.2. Current Market Size Forecast, 2024-2033
  • 3.3. Global Drug Delivery System Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Bn ) & Volume (in Units) Analysis by Product, 2019-2023
    • 3.3.3. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
      • 3.3.3.1. Self-Injector
      • 3.3.3.2. Pre-Filled Needle Free Injectors
      • 3.3.3.3. Auto Injectors
      • 3.3.3.4. Wearable Injectors
      • 3.3.3.5. Insulin Pens
      • 3.3.3.6. Implantable Drug Delivery
      • 3.3.3.7. Transdermal Patches
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global Drug Delivery System Market Outlook: Usage
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Bn ) Analysis by Usage, 2019-2023
    • 3.5.3. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
      • 3.5.3.1. Reusable Devices
      • 3.5.3.2. Disposable Devices
  • 3.6. Market Attractiveness Analysis: Usage
  • 3.7. Global Drug Delivery System Market Outlook: Application
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Bn ) Analysis by Application, 2019-2023
    • 3.7.3. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
      • 3.7.3.1. Diabetes
      • 3.7.3.2. Anaphylaxis
      • 3.7.3.3. Rheumatoid Arthritis
      • 3.7.3.4. Cancer
      • 3.7.3.5. Hormonal Therapy
      • 3.7.3.6. Ophthalmology
      • 3.7.3.7. Others
  • 3.8. Market Attractiveness Analysis: Application
  • 3.9. Global Drug Delivery System Market Outlook: Route of Administration
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Bn ) Analysis by Route of Administration, 2019-2023
    • 3.9.3. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
      • 3.9.3.1. Transdermal
      • 3.9.3.2. Subcutaneous
      • 3.9.3.3. Intramuscular
      • 3.9.3.4. Implantable
  • 3.10. Market Attractiveness Analysis: Route of Administration
  • 3.11. Global Drug Delivery System Market Outlook: Sales Channel
    • 3.11.1. Introduction / Key Findings
    • 3.11.2. Historical Market Size (US$ Bn ) Analysis by Sales Channel, 2019-2023
    • 3.11.3. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
      • 3.11.3.1. Hospitals
      • 3.11.3.2. Specialty Clinics
      • 3.11.3.3. Retail Pharmacy Chains
      • 3.11.3.4. Drug Stores
      • 3.11.3.5. Online Sales Channel
  • 3.12. Market Attractiveness Analysis: Sales Channel

4. Global Drug Delivery System Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Bn ) Analysis by Region, 2019-2023
  • 4.3. Current Market Size (US$ Bn ) Forecast by Region, 2024-2033
    • 4.3.1. North America
    • 4.3.2. Latin America
    • 4.3.3. Western Europe
    • 4.3.4. Eastern Europe
    • 4.3.5. East Asia
    • 4.3.6. South Asia & Pacific
    • 4.3.7. Middle East & Africa
  • 4.4. Market Attractiveness Analysis: Region

5. North America Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
    • 5.2.1. By Country
    • 5.2.2. By Product
    • 5.2.3. By Usage
    • 5.2.4. By Application
    • 5.2.5. By Route of Administration
    • 5.2.6. By Sales Channel
  • 5.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
    • 5.3.1. U.S.
    • 5.3.2. Canada
  • 5.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
    • 5.4.1. Self-Injector
    • 5.4.2. Pre-Filled Needle Free Injectors
    • 5.4.3. Auto Injectors
    • 5.4.4. Wearable Injectors
    • 5.4.5. Insulin Pens
    • 5.4.6. Implantable Drug Delivery
    • 5.4.7. Transdermal Patches
  • 5.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
    • 5.5.1. Reusable Devices
    • 5.5.2. Disposable Devices
  • 5.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
    • 5.6.1. Diabetes
    • 5.6.2. Anaphylaxis
    • 5.6.3. Rheumatoid Arthritis
    • 5.6.4. Cancer
    • 5.6.5. Hormonal Therapy
    • 5.6.6. Ophthalmology
    • 5.6.7. Others
  • 5.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
    • 5.7.1. Transdermal
    • 5.7.2. Subcutaneous
    • 5.7.3. Intramuscular
    • 5.7.4. Implantable
  • 5.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
    • 5.8.1. Hospitals
    • 5.8.2. Specialty Clinics
    • 5.8.3. Retail Pharmacy Chains
    • 5.8.4. Drug Stores
    • 5.8.5. Online Sales Channel
  • 5.9. Market Attractiveness Analysis

6. Western Europe Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Usage
    • 6.2.4. By Application
    • 6.2.5. By Route of Administration
    • 6.2.6. By Sales Channel
  • 6.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
    • 6.3.1. Germany
    • 6.3.2. Italy
    • 6.3.3. France
    • 6.3.4. U.K.
    • 6.3.5. Spain
    • 6.3.6. BENELUX
    • 6.3.7. Nordic Countries
    • 6.3.8. Rest of Western Europe
  • 6.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
    • 6.4.1. Self-Injector
    • 6.4.2. Pre-Filled Needle Free Injectors
    • 6.4.3. Auto Injectors
    • 6.4.4. Wearable Injectors
    • 6.4.5. Insulin Pens
    • 6.4.6. Implantable Drug Delivery
    • 6.4.7. Transdermal Patches
  • 6.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
    • 6.5.1. Reusable Devices
    • 6.5.2. Disposable Devices
  • 6.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
    • 6.6.1. Diabetes
    • 6.6.2. Anaphylaxis
    • 6.6.3. Rheumatoid Arthritis
    • 6.6.4. Cancer
    • 6.6.5. Hormonal Therapy
    • 6.6.6. Ophthalmology
    • 6.6.7. Others
  • 6.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
    • 6.7.1. Transdermal
    • 6.7.2. Subcutaneous
    • 6.7.3. Intramuscular
    • 6.7.4. Implantable
  • 6.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
    • 6.8.1. Hospitals
    • 6.8.2. Specialty Clinics
    • 6.8.3. Retail Pharmacy Chains
    • 6.8.4. Drug Stores
    • 6.8.5. Online Sales Channel
  • 6.9. Market Attractiveness Analysis

7. Eastern Europe Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Usage
    • 7.2.4. By Application
    • 7.2.5. By Route of Administration
    • 7.2.6. By Sales Channel
  • 7.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
    • 7.3.1. Poland
    • 7.3.2. Hungary
    • 7.3.3. Russia
    • 7.3.4. Balkan & Baltic
    • 7.3.5. Rest of Eastern Europe
  • 7.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
    • 7.4.1. Self-Injector
    • 7.4.2. Pre-Filled Needle Free Injectors
    • 7.4.3. Auto Injectors
    • 7.4.4. Wearable Injectors
    • 7.4.5. Insulin Pens
    • 7.4.6. Implantable Drug Delivery
    • 7.4.7. Transdermal Patches
  • 7.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
    • 7.5.1. Reusable Devices
    • 7.5.2. Disposable Devices
  • 7.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
    • 7.6.1. Diabetes
    • 7.6.2. Anaphylaxis
    • 7.6.3. Rheumatoid Arthritis
    • 7.6.4. Cancer
    • 7.6.5. Hormonal Therapy
    • 7.6.6. Ophthalmology
    • 7.6.7. Others
  • 7.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
    • 7.7.1. Transdermal
    • 7.7.2. Subcutaneous
    • 7.7.3. Intramuscular
    • 7.7.4. Implantable
  • 7.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
    • 7.8.1. Hospitals
    • 7.8.2. Specialty Clinics
    • 7.8.3. Retail Pharmacy Chains
    • 7.8.4. Drug Stores
    • 7.8.5. Online Sales Channel
  • 7.9. Market Attractiveness Analysis

8. East Asia Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Usage
    • 8.2.4. By Application
    • 8.2.5. By Route of Administration
    • 8.2.6. By Sales Channel
  • 8.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
    • 8.4.1. Self-Injector
    • 8.4.2. Pre-Filled Needle Free Injectors
    • 8.4.3. Auto Injectors
    • 8.4.4. Wearable Injectors
    • 8.4.5. Insulin Pens
    • 8.4.6. Implantable Drug Delivery
    • 8.4.7. Transdermal Patches
  • 8.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
    • 8.5.1. Reusable Devices
    • 8.5.2. Disposable Devices
  • 8.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
    • 8.6.1. Diabetes
    • 8.6.2. Anaphylaxis
    • 8.6.3. Rheumatoid Arthritis
    • 8.6.4. Cancer
    • 8.6.5. Hormonal Therapy
    • 8.6.6. Ophthalmology
    • 8.6.7. Others
  • 8.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
    • 8.7.1. Transdermal
    • 8.7.2. Subcutaneous
    • 8.7.3. Intramuscular
    • 8.7.4. Implantable
  • 8.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
    • 8.8.1. Hospitals
    • 8.8.2. Specialty Clinics
    • 8.8.3. Retail Pharmacy Chains
    • 8.8.4. Drug Stores
    • 8.8.5. Online Sales Channel
  • 8.9. Market Attractiveness Analysis

9. South Asia & Pacific Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Usage
    • 9.2.4. By Application
  • 9.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
    • 9.3.1. India
    • 9.3.2. Thailand
    • 9.3.3. Indonesia
    • 9.3.4. Malaysia
    • 9.3.5. Philippines
    • 9.3.6. Vietnam
    • 9.3.7. Australia & New Zealand
    • 9.3.8. Rest of South Asia & Pacific
  • 9.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
    • 9.4.1. Self-Injector
    • 9.4.2. Pre-Filled Needle Free Injectors
    • 9.4.3. Auto Injectors
    • 9.4.4. Wearable Injectors
    • 9.4.5. Insulin Pens
    • 9.4.6. Implantable Drug Delivery
    • 9.4.7. Transdermal Patches
  • 9.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
    • 9.5.1. Reusable Devices
    • 9.5.2. Disposable Devices
  • 9.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
    • 9.6.1. Diabetes
    • 9.6.2. Anaphylaxis
    • 9.6.3. Rheumatoid Arthritis
    • 9.6.4. Cancer
    • 9.6.5. Hormonal Therapy
    • 9.6.6. Ophthalmology
    • 9.6.7. Others
  • 9.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
    • 9.7.1. Transdermal
    • 9.7.2. Subcutaneous
    • 9.7.3. Intramuscular
    • 9.7.4. Implantable
  • 9.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
    • 9.8.1. Hospitals
    • 9.8.2. Specialty Clinics
    • 9.8.3. Retail Pharmacy Chains
    • 9.8.4. Drug Stores
    • 9.8.5. Online Sales Channel
  • 9.9. Market Attractiveness Analysis

10. Latin America Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Usage
    • 10.2.4. By Application
    • 10.2.5. By Route of Administration
    • 10.2.6. By Sales Channel
  • 10.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Chile
    • 10.3.4. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
    • 10.4.1. Self-Injector
    • 10.4.2. Pre-Filled Needle Free Injectors
    • 10.4.3. Auto Injectors
    • 10.4.4. Wearable Injectors
    • 10.4.5. Insulin Pens
    • 10.4.6. Implantable Drug Delivery
    • 10.4.7. Transdermal Patches
  • 10.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
    • 10.5.1. Reusable Devices
    • 10.5.2. Disposable Devices
  • 10.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
    • 10.6.1. Diabetes
    • 10.6.2. Anaphylaxis
    • 10.6.3. Rheumatoid Arthritis
    • 10.6.4. Cancer
    • 10.6.5. Hormonal Therapy
    • 10.6.6. Ophthalmology
    • 10.6.7. Others
  • 10.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
    • 10.7.1. Transdermal
    • 10.7.2. Subcutaneous
    • 10.7.3. Intramuscular
    • 10.7.4. Implantable
  • 10.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
    • 10.8.1. Hospitals
    • 10.8.2. Specialty Clinics
    • 10.8.3. Retail Pharmacy Chains
    • 10.8.4. Drug Stores
    • 10.8.5. Online Sales Channel
  • 10.9. Market Attractiveness Analysis

11. Middle East & Africa Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Usage
    • 11.2.4. By Application
    • 11.2.5. By Route of Administration
    • 11.2.6. By Sales Channel
  • 11.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
    • 11.3.1. Kingdom of Saudi Arabia
    • 11.3.2. GCC Countries
    • 11.3.3. Turkey
    • 11.3.4. Israel
    • 11.3.5. Other African Union
    • 11.3.6. South Africa
    • 11.3.7. Rest of Middle East and Africa
  • 11.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
    • 11.4.1. Self-Injector
    • 11.4.2. Pre-Filled Needle Free Injectors
    • 11.4.3. Auto Injectors
    • 11.4.4. Wearable Injectors
    • 11.4.5. Insulin Pens
    • 11.4.6. Implantable Drug Delivery
    • 11.4.7. Transdermal Patches
  • 11.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
    • 11.5.1. Reusable Devices
    • 11.5.2. Disposable Devices
  • 11.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
    • 11.6.1. Diabetes
    • 11.6.2. Anaphylaxis
    • 11.6.3. Rheumatoid Arthritis
    • 11.6.4. Cancer
    • 11.6.5. Hormonal Therapy
    • 11.6.6. Ophthalmology
    • 11.6.7. Others
  • 11.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
    • 11.7.1. Transdermal
    • 11.7.2. Subcutaneous
    • 11.7.3. Intramuscular
    • 11.7.4. Implantable
  • 11.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
    • 11.8.1. Hospitals
    • 11.8.2. Specialty Clinics
    • 11.8.3. Retail Pharmacy Chains
    • 11.8.4. Drug Stores
    • 11.8.5. Online Sales Channel
  • 11.9. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Eli Lilly and Company
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Becton Dickinson And Co.
      • 12.3.2.1. Overview
      • 12.3.2.2. Segments and Product
      • 12.3.2.3. Key Financials
      • 12.3.2.4. Market Developments
      • 12.3.2.5. Market Strategy
    • 12.3.3. Novo Nordisk
      • 12.3.3.1. Overview
      • 12.3.3.2. Segments and Product
      • 12.3.3.3. Key Financials
      • 12.3.3.4. Market Developments
      • 12.3.3.5. Market Strategy
    • 12.3.4. Sanofi
      • 12.3.4.1. Overview
      • 12.3.4.2. Segments and Product
      • 12.3.4.3. Key Financials
      • 12.3.4.4. Market Developments
      • 12.3.4.5. Market Strategy
    • 12.3.5. Johnson & Johnson
      • 12.3.5.1. Overview
      • 12.3.5.2. Segments and Product
      • 12.3.5.3. Key Financials
      • 12.3.5.4. Market Developments
      • 12.3.5.5. Market Strategy
    • 12.3.6. Roche
      • 12.3.6.1. Overview
      • 12.3.6.2. Segments and Product
      • 12.3.6.3. Key Financials
      • 12.3.6.4. Market Developments
      • 12.3.6.5. Market Strategy
    • 12.3.7. Pfizer
      • 12.3.7.1. Overview
      • 12.3.7.2. Segments and Product
      • 12.3.7.3. Key Financials
      • 12.3.7.4. Market Developments
      • 12.3.7.5. Market Strategy
    • 12.3.8. AbbVie
      • 12.3.8.1. Overview
      • 12.3.8.2. Segments and Product
      • 12.3.8.3. Key Financials
      • 12.3.8.4. Market Developments
      • 12.3.8.5. Market Strategy
    • 12.3.9. Mylan N.V. (Viatris)
      • 12.3.9.1. Overview
      • 12.3.9.2. Segments and Product
      • 12.3.9.3. Key Financials
      • 12.3.9.4. Market Developments
      • 12.3.9.5. Market Strategy
    • 12.3.10. Insulet corporation
      • 12.3.10.1. Overview
      • 12.3.10.2. Segments and Product
      • 12.3.10.3. Key Financials
      • 12.3.10.4. Market Developments
      • 12.3.10.5. Market Strategy
    • 12.3.11. Medtronic Plc
      • 12.3.11.1. Overview
      • 12.3.11.2. Segments and Product
      • 12.3.11.3. Key Financials
      • 12.3.11.4. Market Developments
      • 12.3.11.5. Market Strategy

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!